{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:12:10Z","timestamp":1788696730183,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with sarcoidosis have an increased risk for calcium metabolism disturbances, such as hypercalcemia and hypercalciuria. Previous studies suggest that nephrolithiasis (stone formation in the renal and ureter, often caused by dysregulated calcium balance) may occur long before sarcoidosis diagnosis and may be an early sign of not-yet-diagnosed sarcoidosis. We hypothesized that a history of nephrolithiasis is associated with future risk of sarcoidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this population-based matched case-control study, we included individuals with sarcoidosis and matched general population controls and identified those with a history of nephrolithiasis in Swedish nationwide registers. Patients with sarcoidosis who received treatment within three months of their sarcoidosis diagnosis were classified as severe. Nephrolithiasis severity was defined based on the need for intervention, multiple stones and early onset. Conditional logistic regression models estimated adjusted odds ratios with 95% confidence intervals (OR; 95%CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 10,904 sarcoidosis patients and 99,211 general population controls were included. At sarcoidosis diagnosis, 4.5% of patients had a history of nephrolithiasis compared to 2.6% of controls. Nephrolithiasis was associated with a 61% increased odds of sarcoidosis (adjusted OR\u2009=\u20091.61; 95%CI 1.46\u20131.78). The OR of severe sarcoidosis associated with a history of severe nephrolithiasis was 1.35 (95%CI 0.58\u20133.16).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate that nephrolithiasis might be an early sign of sarcoidosis in a subset of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03877-y","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:34:11Z","timestamp":1787924051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence for nephrolithiasis preceding sarcoidosis diagnosis: findings from a Swedish case-control study"],"prefix":"10.1186","volume":"27","author":[{"given":"Joanna","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Arkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurgul","family":"Batyrbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"10 Pt 1","key":"3877_CR1","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"29","key":"3877_CR2","doi-asserted-by":"publisher","first-page":"pe7595","DOI":"10.1097\/MD.0000000000007595","volume":"96","author":"J Ma\u00f1\u00e1","year":"2017","unstructured":"Ma\u00f1\u00e1 J, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Med (Baltim). 2017;96(29):pe7595.","journal-title":"Med (Baltim)"},{"key":"3877_CR3","doi-asserted-by":"crossref","unstructured":"Arkema EV et al. Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case-control study in Sweden. Eur Respir J. 2024;64(6):2400277.","DOI":"10.1183\/13993003.00277-2024"},{"issue":"6","key":"3877_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI101084","volume":"18","author":"GT Harrell","year":"1939","unstructured":"Harrell GT, Fisher S. Blood Chemical Changes in Boeck\u2019s Sarcoid with Particular Reference to Protein, Calcium and Phosphatase Values. J Clin Invest. 1939;18(6):687\u201393.","journal-title":"J Clin Invest"},{"issue":"6","key":"3877_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5114\/reum.2018.80715","volume":"56","author":"I Ru\u017ea","year":"2018","unstructured":"Ru\u017ea I, Luc\u0101ne Z. Serum and urinary calcium level in Latvian patients with sarcoidosis. Reumatologia. 2018;56(6):377\u201381.","journal-title":"Reumatologia"},{"issue":"2","key":"3877_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0094-0143(05)70257-3","volume":"27","author":"JS Rodman","year":"2000","unstructured":"Rodman JS, Mahler RJ. Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis. Urol Clin North Am. 2000;27(2):275\u2013viii85.","journal-title":"Urol Clin North Am"},{"key":"3877_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/003693306000500903","volume":"5","author":"GS Anderson","year":"1960","unstructured":"Anderson GS, Graham AG. Renal sarcoidosis and nephrolithiasis. Scott Med J. 1960;5:392\u20136.","journal-title":"Scott Med J"},{"issue":"5","key":"3877_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/thx.50.5.555","volume":"50","author":"G Rizzato","year":"1995","unstructured":"Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax. 1995;50(5):555\u20139.","journal-title":"Thorax"},{"issue":"2","key":"3877_CR9","first-page":"167","volume":"13","author":"G Rizzato","year":"1996","unstructured":"Rizzato G, Colombo P. Nephrolithiasis as a presenting feature of chronic sarcoidosis: a prospective study. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13(2):167\u201372.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"10","key":"3877_CR10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1442-2042.2007.01854.x","volume":"14","author":"Y Kato","year":"2007","unstructured":"Kato Y, et al. Three cases of urolithiasis associated with sarcoidosis: a review of Japanese cases. Int J Urol. 2007;14(10):954\u20136.","journal-title":"Int J Urol"},{"issue":"5","key":"3877_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/jim-2016-000101","volume":"64","author":"G Capolongo","year":"2016","unstructured":"Capolongo G, et al. Vitamin-D status and mineral metabolism in two ethnic populations with sarcoidosis. J Investig Med. 2016;64(5):1025\u201334.","journal-title":"J Investig Med"},{"issue":"8","key":"3877_CR12","first-page":"490","volume":"99","author":"LF Fontenelle","year":"2019","unstructured":"Fontenelle LF, Sarti TD. Kidney Stones: Treatment and Prevention. Am Fam Physician. 2019;99(8):490\u20136.","journal-title":"Am Fam Physician"},{"issue":"12","key":"3877_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.4111\/kju.2011.52.12.847","volume":"52","author":"DU Tchey","year":"2011","unstructured":"Tchey DU, et al. Expectant Management of Ureter Stones: Outcome and Clinical Factors of Spontaneous Passage in a Single Institution\u2019s Experience. Korean J Urol. 2011;52(12):847\u201351.","journal-title":"Korean J Urol"},{"key":"3877_CR14","doi-asserted-by":"crossref","unstructured":"Akram M et al. Urological Guidelines for Kidney Stones: Overview and Comprehensive Update. J Clin Med. 2024;13(4):1114.","DOI":"10.3390\/jcm13041114"},{"issue":"3","key":"3877_CR15","first-page":"333","volume":"45","author":"R Kachkoul","year":"2023","unstructured":"Kachkoul R, et al. Urolithiasis: History, epidemiology, aetiologic factors and management. Malays J Pathol. 2023;45(3):333\u201352.","journal-title":"Malays J Pathol"},{"issue":"12","key":"3877_CR16","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1681\/ASN.2013091011","volume":"25","author":"AD Rule","year":"2014","unstructured":"Rule AD, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25(12):2878\u201386.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3877_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40620-016-0283-8","volume":"30","author":"PM Ferraro","year":"2017","unstructured":"Ferraro PM, et al. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol. 2017;30(2):227\u201333.","journal-title":"J Nephrol"},{"key":"3877_CR18","doi-asserted-by":"crossref","unstructured":"Rossides M et al. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J. 2018;51(2):1701815.","DOI":"10.1183\/13993003.01815-2017"},{"issue":"12","key":"3877_CR19","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.cgh.2020.09.049","volume":"19","author":"H Dimke","year":"2021","unstructured":"Dimke H, et al. Risk of Urolithiasis in Patients With Inflammatory Bowel Disease: A Nationwide Danish Cohort Study 1977\u20132018. Clin Gastroenterol Hepatol. 2021;19(12):2532\u2013e25402.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3877_CR20","doi-asserted-by":"crossref","unstructured":"Rossides M, Kullberg S, Arkema EV. History and familial aggregation of immune-mediated diseases in sarcoidosis: a register-based case-control-family study. Chest. 2024;166(5):1082\u201392.","DOI":"10.1016\/j.chest.2024.05.014"},{"issue":"11","key":"3877_CR21","doi-asserted-by":"publisher","first-page":"e113602","DOI":"10.1371\/journal.pone.0113602","volume":"9","author":"AK Jakobsen","year":"2014","unstructured":"Jakobsen AK, et al. Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects. PLoS ONE. 2014;9(11):e113602.","journal-title":"PLoS ONE"},{"issue":"2","key":"3877_CR22","doi-asserted-by":"publisher","first-page":"105290","DOI":"10.1016\/j.jbspin.2021.105290","volume":"89","author":"R Mazzucchelli","year":"2022","unstructured":"Mazzucchelli R, et al. Association of spondyloarthritis and sarcoidosis: A retrospective observational population-based matched cohort study. Joint Bone Spine. 2022;89(2):105290.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"3877_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40620-022-01369-y","volume":"36","author":"M Calatroni","year":"2023","unstructured":"Calatroni M, et al. Renal sarcoidosis. J Nephrol. 2023;36(1):5\u201315.","journal-title":"J Nephrol"},{"issue":"2","key":"3877_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.juro.2016.12.135","volume":"198","author":"G Gambaro","year":"2017","unstructured":"Gambaro G, et al. The Risk of Chronic Kidney Disease Associated with Urolithiasis and its Urological Treatments: A Review. J Urol. 2017;198(2):268\u201373.","journal-title":"J Urol"},{"issue":"4","key":"3877_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.23736\/S0393-2249.18.03113-2","volume":"70","author":"A Carbone","year":"2018","unstructured":"Carbone A, et al. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018;70(4):393\u2013400.","journal-title":"Minerva Urol Nefrol"},{"key":"3877_CR26","first-page":"237","volume":"8","author":"D Wambui","year":"2020","unstructured":"Wambui D. Association Between Obesity and Sarcoidosis: A Systematic Review and Meta-analysis. Am J Intern Med. 2020;8:237\u201345.","journal-title":"Am J Intern Med"},{"key":"3877_CR27","doi-asserted-by":"crossref","unstructured":"Entrop JP et al. Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids. ERJ Open Res. 2021;7(2) :00028\u20132021.","DOI":"10.1183\/23120541.00028-2021"},{"issue":"3","key":"3877_CR28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1523-1755.2005.00516.x","volume":"68","author":"EN Taylor","year":"2005","unstructured":"Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230\u20135.","journal-title":"Kidney Int"},{"key":"3877_CR29","doi-asserted-by":"crossref","unstructured":"Messa P et al. Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship. Nutrients. 2023;15(7):1724.","DOI":"10.3390\/nu15071724"},{"issue":"5","key":"3877_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1055\/s-0040-1713009","volume":"41","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Lower EE. Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis. Semin Respir Crit Care Med. 2020;41(5):618\u201325.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"3877_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11605-018-4035-z","volume":"23","author":"KL Lak","year":"2019","unstructured":"Lak KL, et al. Metabolic Syndrome Is a Significant Predictor of Postoperative Morbidity and Mortality Following Bariatric Surgery. J Gastrointest Surg. 2019;23(4):739\u201344.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"3877_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00345-025-05923-8","volume":"44","author":"GS Marchini","year":"2026","unstructured":"Marchini GS, et al. Nephrolithiasis in sarcoidosis: epidemiology, risk factors, and clinical implications. World J Urol. 2026;44(1):139.","journal-title":"World J Urol"},{"key":"3877_CR33","doi-asserted-by":"crossref","unstructured":"McAllister TR et al. Sarcoidosis and Risk of Nephrolithiasis in US Black Women: Data from the Black Women\u2019s Health Study. CHEST Pulm. 2025;3(4):100193.","DOI":"10.1016\/j.chpulm.2025.100193"},{"key":"3877_CR34","doi-asserted-by":"publisher","first-page":"105846","DOI":"10.1016\/j.rmed.2019.105846","volume":"161","author":"M Rossides","year":"2020","unstructured":"Rossides M, et al. Sarcoidosis diagnosis and treatment in Sweden: A register-based assessment of variations by region and calendar period. Respir Med. 2020;161:105846.","journal-title":"Respir Med"},{"issue":"4","key":"3877_CR35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/ejh.12504","volume":"95","author":"V Komninaka","year":"2015","unstructured":"Komninaka V, et al. Evaluation of bone involvement in patients with Gaucher disease: a semi-quantitative magnetic resonance imaging method (using ROI estimation of bone lesion) as an alternative method to semi-quantitative methods used so far. Eur J Haematol. 2015;95(4):342\u201351.","journal-title":"Eur J Haematol"},{"issue":"4","key":"3877_CR36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbrc.2005.03.085","volume":"330","author":"HB Kwak","year":"2005","unstructured":"Kwak HB, et al. Tumor necrosis factor-alpha induces differentiation of human peripheral blood mononuclear cells into osteoclasts through the induction of p21(WAF1\/Cip1). Biochem Biophys Res Commun. 2005;330(4):1080\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"3877_CR37","doi-asserted-by":"publisher","first-page":"106537","DOI":"10.1016\/j.rmed.2021.106537","volume":"187","author":"J Werner","year":"2021","unstructured":"Werner J, et al. HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis. Respir Med. 2021;187:106537.","journal-title":"Respir Med"},{"key":"3877_CR38","doi-asserted-by":"publisher","first-page":"103207","DOI":"10.1016\/j.jaut.2024.103207","volume":"149","author":"F Bonella","year":"2024","unstructured":"Bonella F, Dm A, Vorselaars, Wilde B. Kidney manifestations of sarcoidosis. J Autoimmun. 2024;149:103207.","journal-title":"J Autoimmun"},{"key":"3877_CR39","doi-asserted-by":"publisher","first-page":"147997311987871","DOI":"10.1177\/1479973119878713","volume":"16","author":"\u0141 Gwadera","year":"2019","unstructured":"Gwadera \u0141, et al. Sarcoidosis and calcium homeostasis disturbances-Do we know where we stand? Chron Respir Dis. 2019;16:1479973119878713.","journal-title":"Chron Respir Dis"},{"issue":"5","key":"3877_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00063198-200009000-00010","volume":"6","author":"OP Sharma","year":"2000","unstructured":"Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med. 2000;6(5):442\u20137.","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"3877_CR41","first-page":"380","volume":"34","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, et al. Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol. 2016;34(3):380\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3877_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10654-023-01084-3","volume":"39","author":"M Dehara","year":"2024","unstructured":"Dehara M, et al. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden. Eur J Epidemiol. 2024;39(3):313\u201322.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3877_CR43","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.juro.2018.04.080","volume":"200","author":"M Prochaska","year":"2018","unstructured":"Prochaska M, Taylor EN, Curhan G. Menopause and Risk of Kidney Stones. J Urol. 2018;200(4):823\u20138.","journal-title":"J Urol"},{"key":"3877_CR44","doi-asserted-by":"publisher","first-page":"106688","DOI":"10.1016\/j.rmed.2021.106688","volume":"191","author":"A Lundkvist","year":"2022","unstructured":"Lundkvist A, et al. Differences in disease presentation between men and women with sarcoidosis: A cohort study. Respir Med. 2022;191:106688.","journal-title":"Respir Med"},{"key":"3877_CR45","doi-asserted-by":"crossref","unstructured":"Drent M et al. Is a Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism a Risk Factor for Nephrolithiasis in Sarcoidosis? Int J Mol Sci. 2024;25(8):4448.","DOI":"10.3390\/ijms25084448"},{"issue":"4","key":"3877_CR46","first-page":"354","volume":"123","author":"M Henderickx","year":"2023","unstructured":"Henderickx M, et al. Could the region you live in prevent or precipitate kidney stone formation due to mineral intake through tap water? An analysis of nine distribution regions in Flanders. Acta Chir Belg. 2023;123(4):354\u201361.","journal-title":"Acta Chir Belg"},{"key":"3877_CR47","unstructured":"Sgu. Uppsala: Sveriges geologiska unders\u00f6kning; 2026. Available from: https:\/\/www.sgu.se\/anvandarstod-for-geologiska-fragor\/bedomningsgrunder-for-grundvatten\/grundvattnets-kvalitet--oorganiska-amnen\/kalcium\/. Accessed 7 January 2026."},{"key":"3877_CR48","doi-asserted-by":"crossref","unstructured":"Stoots SJM et al. Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological Diseases. J Clin Med. 2021;10(13):2807.","DOI":"10.3390\/jcm10132807"},{"issue":"3","key":"3877_CR49","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/EDE.0000000000001323","volume":"32","author":"S Ceder","year":"2021","unstructured":"Ceder S, et al. Positive Predictive Value of Sarcoidosis Identified in an Administrative Healthcare Registry: A Validation Study. Epidemiology. 2021;32(3):444\u20137.","journal-title":"Epidemiology"},{"issue":"1","key":"3877_CR50","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.juro.2010.03.011","volume":"184","author":"MJ Semins","year":"2010","unstructured":"Semins MJ, Trock BJ, Matlaga BR. Validity of administrative coding in identifying patients with upper urinary tract calculi. J Urol. 2010;184(1):190\u20132.","journal-title":"J Urol"},{"issue":"12","key":"3877_CR51","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41581-020-0320-7","volume":"16","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Krambeck AE, Rule AD. Determining the true burden of kidney stone disease. Nat Rev Nephrol. 2020;16(12):736\u201346.","journal-title":"Nat Rev Nephrol"},{"key":"3877_CR52","doi-asserted-by":"crossref","unstructured":"Della Zoppa M et al. Phenotypes and Serum Biomarkers in Sarcoidosis. Diagnostics (Basel). 2024;14(7):709.","DOI":"10.3390\/diagnostics14070709"},{"issue":"10","key":"3877_CR53","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.mayocp.2015.07.016","volume":"90","author":"P Singh","year":"2015","unstructured":"Singh P, et al. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community. Mayo Clin Proc. 2015;90(10):1356\u201365.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"3877_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0002-9343(99)80080-1","volume":"98","author":"FL Levy","year":"1995","unstructured":"Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98(1):50\u20139.","journal-title":"Am J Med"},{"issue":"9","key":"3877_CR55","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin I, et al. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301\u201320.","journal-title":"World J Urol"},{"issue":"1","key":"3877_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/oby.2004.14","volume":"12","author":"R Siener","year":"2004","unstructured":"Siener R, et al. The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004;12(1):106\u201313.","journal-title":"Obes Res"},{"key":"3877_CR57","doi-asserted-by":"crossref","unstructured":"Dehara M et al. Modifiable lifestyle risk factors for sarcoidosis: a nested case-control study. ERJ Open Res. 2023;9(2):00492\u20132022.","DOI":"10.1183\/23120541.00492-2022"},{"issue":"3","key":"3877_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10654-025-01221-0","volume":"40","author":"\u00c5 Everhov","year":"2025","unstructured":"Everhov \u00c5. Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register. Eur J Epidemiol. 2025;40(3):359\u201369.","journal-title":"Eur J Epidemiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03877-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03877-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T11:50:26Z","timestamp":1788695426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03877-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3877"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03877-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Regional Ethical Review Board in Stockholm (DNR: 2014\/230-31, 2021-01856).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"345"}}